|
Bionumbers is a resource for Drug Delivery and Specialty Pharma companies providing reliable facts and figures that impact pipeline and business decisions. Articles, analyses and indexes are provided free-of-charge. Bionumbers also publishes one-of-a-kind reports based on proprietary research. |
|
DDEP09 - Parameters of Performance Series: An Abridged Overview of Key Parameters That Impact the Clinical Development & Approval of Drug Delivery Enabled/Enhanced Pharmaceutical Products We are now making available at no charge an abridged version of our 2009 report that analyzed the development times and success rates for drug delivery enabled/enhanced products. This will be a valuable resource for all of you developing pipeline performance estimates and forecasts. |
|
Now Available |
|
What’s New July 5, 2010 Index - 2010 June Close CSP Index ESP Index DD Index - DD09 Available Key numbers that define the norms for drug delivery product development. - Recent Articles “Oral Drug Delivery: The Numbers Behind the Business”, (OnDrugDELIVERY, June 2010, Page 4) “Drug Delivery Products & Technologies, a Decade in Review: Approved Products 2000 to 2009” “Opening the Black Box” February issue PMPS (UK) - “Product Development Expectations & the Real World”, (Drug Delivery Technology Magazine - January 2010 Issue)
|
|
The three biopharma indexes go back to December 2004 and include commercial stage specialty pharma (CSP), emerging stage specialty pharma (ESP) and drug delivery (DDI) indexes. |
|
2010 Latest Index Snapshot |
|
Bionumbers Index one-page summary in Adobe Acrobat format available. |
